scholarly article | Q13442814 |
P50 | author | Javier Garzón | Q44348750 |
Pilar Sanchez Blazquez | Q67590819 | ||
P2093 | author name string | M Rodríguez-Díaz | |
A López-Fando | |||
P2860 | cites work | A G protein γ subunit-like domain shared between RGS11 and other RGS proteins specifies binding to G β5 subunits | Q22004020 |
RGS2/G0S8 is a selective inhibitor of Gqα function | Q24648296 | ||
Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis | Q27736041 | ||
RGS10 is a selective activator of G alpha i GTPase activity | Q28287882 | ||
The GTPase activating factor for transducin in rod photoreceptors is the complex between RGS9 and type 5 G protein beta subunit | Q28609908 | ||
LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor | Q31988110 | ||
Emerging roles for RGS proteins in cell signalling | Q33720599 | ||
Molecular and Cellular Basis of Addiction | Q34440561 | ||
RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha | Q35951781 | ||
Evidence that the nucleotide exchange and hydrolysis cycle of G proteins causes acute desensitization of G-protein gated inward rectifier K + channels | Q36319780 | ||
The application of antisense oligonucleotide technology to the brain: some pitfalls | Q38304029 | ||
In vivo modulation of G proteins and opioid receptor function by antisense oligodeoxynucleotides. | Q38318349 | ||
Mammalian RGS Proteins: Barbarians at the Gate | Q41682826 | ||
Regulators of G protein signaling (RGS) proteins constitutively activate Gbeta gamma-gated potassium channels | Q42463888 | ||
Multiple Output Channels in the Basal Ganglia | Q42482773 | ||
Axonal branching of basal forebrain projections to the neocortex: a double-labeling study in the cat. | Q42487011 | ||
Single-dose tolerance to antinociception, and physical dependence on beta-endorphin in mice | Q43846737 | ||
Antisera against the 3-17 sequence of rat G alpha i recognize only a 40 kDa G-protein in brain | Q44097341 | ||
Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla | Q44336043 | ||
Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance | Q44337011 | ||
Influence of Gz and Gi2 transducer proteins in the affinity of opioid agonists to mu receptors. | Q44350218 | ||
Mu-opioid agonist-induced activation of G-protein-coupled inwardly rectifying potassium current in rat periaqueductal gray neurons | Q44351732 | ||
Regulators of G protein signaling proteins as determinants of the rate of desensitization of presynaptic calcium channels | Q47966163 | ||
Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray | Q48363900 | ||
Organization of cerebral cortical afferent systems in the rat. II. Hypothalamocortical projections | Q48476659 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | opioid | Q427523 |
P304 | page(s) | 801-811 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | European Journal of Neuroscience | Q5412733 |
P1476 | title | RGS9 proteins facilitate acute tolerance to mu-opioid effects | |
P478 | volume | 13 |
Q33754558 | A dopaminergic gene cluster in the prefrontal cortex predicts performance indicative of general intelligence in genetically heterogeneous mice |
Q36732984 | Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice |
Q92967463 | Acute Tramadol-Induced Cellular Tolerance and Dependence of Ventral Tegmental Area Dopaminergic Neurons: An In Vivo Electrophysiological Study |
Q35118220 | An essential role for RGS protein/Gαi2 interactions in B lymphocyte-directed cell migration and trafficking |
Q37726368 | Biology and functions of the RGS9 isoforms |
Q37192031 | Changes in striatal signaling induce remodeling of RGS complexes containing Gbeta5 and R7BP subunits |
Q28245135 | Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS |
Q40678245 | Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways |
Q24655663 | Essential role for RGS9 in opiate action |
Q37999097 | Evidence from basic research for opioid combinations |
Q44342499 | Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats |
Q44938371 | Expression of neural RGS-R7 and Gbeta5 Proteins in Response to Acute and Chronic Morphine. |
Q24658414 | Functional comparison of RGS9 splice isoforms in a living cell |
Q43996585 | Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain |
Q41958365 | Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine |
Q35652043 | How regulators of G protein signaling achieve selective regulation |
Q82899954 | Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance |
Q36184484 | Look before leaping: combined opioids may not be the rave |
Q35864208 | Measuring the modulatory effects of RGS proteins on GIRK channels. |
Q35177403 | Molecular basis of opioid dependence: role of signal regulation by G-proteins |
Q21223665 | Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins |
Q38105951 | Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling. |
Q39157737 | Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain |
Q37726361 | Nuclear trafficking of regulator of G protein signaling proteins and their roles in the nucleus. |
Q38085387 | Opioid receptor interacting proteins and the control of opioid signaling. |
Q35906057 | RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives |
Q38344148 | RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance |
Q28570437 | Receptor-selective effects of endogenous RGS3 and RGS5 to regulate mitogen-activated protein kinase activation in rat vascular smooth muscle cells |
Q44373732 | Regulation of RGS proteins by chronic morphine in rat locus coeruleus |
Q37228167 | Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptors |
Q89619696 | Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management |
Q35015775 | Regulators of G protein signaling (RGS proteins): novel central nervous system drug targets |
Q44485238 | Specificity of G protein-RGS protein recognition is regulated by affinity adapters |
Q24643521 | The R7 RGS protein family: multi-subunit regulators of neuronal G protein signaling |
Q38351795 | The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opioid receptors |
Q34411115 | The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins. |
Q40198648 | The membrane anchor R7BP controls the proteolytic stability of the striatal specific RGS protein, RGS9-2. |
Q40225855 | Untangling ligand induced activation and desensitization of G-protein-coupled receptors |
Q43832333 | Up-regulation of RGS4 mRNA by opioid receptor agonists in PC12 cells expressing cloned mu- or kappa-opioid receptors |
Q26991859 | μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: From a symposium on new concepts in mu-opioid pharmacology |
Search more.